Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation26/07/2024PR Newswire
Warner Bros. World™ Yas Island, Abu Dhabi soars to new heights with Etihad Airways partnership26/07/2024PR Newswire
Xinhua Silk Road: เมืองฮาร์บินทางตะวันออกเฉียงเหนือของจีน กลายเป็นจุดหมายยอดนิยมสำหรับการท่องเที่ยวหน้าร้อน ดึงดูดนักท่องเที่ยวด้วยความงามของพื้นที่ชุ่มน้ำ26/07/2024PR Newswire
ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders26/07/2024PR Newswire
WiMi Built an Advanced Data Structure Architecture Using Homomorphic Encryption and Federated Learning26/07/2024PR Newswire
MHX Jakarta 18-21 July 2024 Wrapped Up with Record Turnout, High Leads Generation and Strategic Partnerships26/07/2024PR Newswire
CougarD Soars with 115% User Surge: New Video Verification Feature Drives Unprecedented Growth26/07/2024PR Newswire
Xinhua Silk Road: NE. China’s Harbin becomes popular summer tourism destination with rich wetland resources26/07/2024PR Newswire
CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer26/07/2024PR Newswire
